TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 3 | 0 | 1 | 2 | -3 | -15 | -5 | -3 |
| S | %wins | 67 | 33 | 33 | 67 | 67 | 67 | 56 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/26/15 18:04 | 1/23/15 | AGTC | Applied Genetic Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Menichella Daniel L | FL | O | VP,Chief | S.d | -50 | 24.90 | 3 | -2 | -100 | 0 | D | 54 | 34 | 13 | 13 | 13 | -2 | 0 | 3 | -12 | -11 | -27 | -34 | ||
12/23/14 14:54 | 12/22/14 | AGTC | Applied Genetic Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Menichella Daniel L | FL | O | VP,Chief | S.d | -187 | 20.83 | 1 | -9 | -100 | 0 | D | -33 | 27 | -19 | -1 | -1 | 0 | -1 | 3 | 14 | -4 | -22 | -7 | ||
9/1/10 18:27 | 8/30/10 | V | Talecris Biotherapeutics Holdings Corp. | DE | Health | Drug | Pharmaceutical Preparations | Menichella Daniel L | NC | O | SVP,Busi | S | -2,205 | 22.05 | 33 | -100 | -85 | 17 | D | -8 | -2 | -20 | -3 | -5 | -6 | -2 | -1 | 2 | -3 | 5 | 5 | 5 | 26 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |